TABLE 2.
Mean ± (SD) for the outcomes related to substance use, craving, anxiety and depression at baseline (T0) for the total sample and by group.
| Outcome | Total sample (n = 111) | Omega-3 (n = 59) | Placebo (n = 52) | P |
| Number of days of consumptiona in the last 30 days | 3.48 (6.23) | 3.93 (6.81) | 2.97 (5.54) | 0.49 |
| Alcoholic drinks consumedb in the last 30 days | 13.95 (35.59) | 10.98 (33.87) | 10 (28.73) | 0.87 |
| Craving intensity (PACS)b | 12.06 (8.28) | 12.22 (8.06) | 11.87 (8.60) | 0.82 |
| Compulsive behaviors (OCDS)b | 9.83 (5.92) | 9.42 (6.04) | 10.29 (5.82) | 0.46 |
| Obsessive behaviors (OCDS)b | 18.03 (8.20) | 17.53 (8.31) | 18.59 (8.13) | 0.51 |
| Dependence severity (SADD)b | 26.12 (10.89) | 26.19 (10.70) | 26.04 (11.21) | 0.94 |
| Anxiety (BAI)b | 17.14 (14.18) | 15.52 (13.17) | 19.04 (15.20) | 0.21 |
| Depression (BDI)b | 18.95 (11.33) | 19.23 (11.68) | 18.61 (11.00) | 0.78 |
The analysis used Poissona or linearb regression models to compare the groups at baseline. PACS, Penn Alcohol Craving Scale; OCDS, Obsessive-Compulsive Drinking Scale; SADD, Short Alcohol Dependence Data; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory.